Skip to main content
PeopleBio, Inc. logo

PeopleBio, Inc. — Investor Relations & Filings

Ticker · 304840 ISIN · KR7304840002 KO Manufacturing
Open in API
Filings indexed 250 across all filing types
Latest filing 2026-05-19 Regulatory Filings
Country KR South Korea
Listing KO 304840

About PeopleBio, Inc.

http://www.peoplebio.net/en/PEOPLEBIO.p…

PeopleBio, Inc. is a biotechnology company specializing in the development and manufacturing of diagnostic products for protein misfolding diseases. The company's primary focus is on degenerative brain disorders, particularly Alzheimer's disease. It develops blood-based diagnostic kits and immunoassays designed for early detection. By providing tools for early diagnosis, PeopleBio aims to facilitate timely intervention and treatment, thereby improving patient outcomes for these conditions.

Recent filings

Filing Released Lang Actions
본점소재지변경
Regulatory Filings Classification · 90% confidence The document is a corporate disclosure about the change of the company’s head office address (본점소재지변경). This is not an AGM material, financial report, management or board appointment, dividend notice, or any other specific category. It is a routine regulatory announcement of a corporate change, falling under the general Regulatory Filings category (RNS).
2026-05-19 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 94% confidence The document is titled “분기보고서” for the period 2026-01-01 to 2026-03-31, contains comprehensive financial statements, management discussion, risk disclosures, operational and segment data typical of a full interim/quarterly report rather than a brief announcement. It is therefore classified as an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 91% confidence The document is an official notice detailing the results of an extraordinary shareholders’ meeting (EGM), including voting outcomes for each agenda item, approval rates, and detailed resolutions. This matches the definition for “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-05-12 Korean
대표이사변경
Board/Management Information Classification · 90% confidence The document is an announcement of a change in the company’s 대표이사 (CEO), detailing the outgoing and incoming representatives and their backgrounds. This is a management/board change notice, fitting the Board/Management Information category.
2026-05-12 Korean
[기재정정]주요사항보고서(유상증자결정)
Capital/Financing Update Classification · 100% confidence The document is a detailed disclosure about a capital increase through a third-party allotment (유상증자결정), including specifics such as the number and type of shares, pricing, subscription dates, and regulatory references. It is addressed to the Financial Services Commission and the Korea Exchange, indicating a formal regulatory filing. The content focuses on the capital raising activity, including changes to the listing date and detailed explanations of the issuance process and related corporate governance provisions. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length is over 5,000 characters and contains substantive details, so it is not merely an announcement of a report but the actual disclosure of the capital increase decision.
2026-05-06 Korean
타인에대한담보제공결정
Capital/Financing Update Classification · 75% confidence The document is a formal disclosure under the Capital Markets Act (자본시장법) detailing the board resolution to provide collateral for third-party borrowings, including debtors, creditors, collateral amount, assets pledged, and debtor financials. This is not an earnings release, M&A, management change, or annual/interim report. It describes a financing-related action (providing collateral to secure debt obligations), which best fits the “Capital/Financing Update” category (CAP).
2026-04-27 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.